Beata Styka, MD
Geriatric Medicine · Palos Heights, ILNPI 1275623233
Payments from drug & device makers
Across 403 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- GSK$937
- AstraZeneca$483
- AbbVie$482
- Lilly USA, LLC$292
- Johnson & Johnson$207
- plus $2K from 29 others
What the payments were for
- Food & beverage$6,391100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 156 | $1,804 |
| GSK | 46 | $937 |
| AstraZeneca | 14 | $483 |
| AbbVie(2 entities) | 28 | $482 |
| Lilly USA, LLC | 16 | $292 |
| Johnson & Johnson | 8 | $207 |
| Novo Nordisk | 12 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $202 |
| Boehringer Ingelheim | 10 | $197 |
| E.r. Squibb & Sons, L.L.C. | 23 | $191 |
| Otsuka America Pharmaceutical, Inc. | 10 | $188 |
| Exact Sciences | 6 | $112 |
| Amarin Pharma, Inc. | 6 | $108 |
| Mylan Specialty L.p. | 5 | $98 |
| Amgen | 6 | $98 |
| Astellas Pharma US Inc | 5 | $84 |
| Novartis | 5 | $82 |
| Phathom Pharmaceuticals, Inc. | 4 | $80 |
| Merck | 5 | $74 |
| Aimmune Therapeutics, Inc. | 3 | $67 |
| Eisai Inc. | 3 | $53 |
| Corium, LLC | 2 | $49 |
| Kowa Pharmaceuticals America, Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $37 |
| Viatris Specialty LLC | 2 | $36 |
| Hikma Pharmaceuticals USA | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Edwards Lifesciences | 1 | $20 |
| Shire North American Group Inc | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Almatica Pharma LLC | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
| Eyevance Pharmaceuticals LLC | 1 | $14 |
| Dermira, Inc. | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$124
How this compares
$6,391 in reported general payments places this provider in the 95th percentile of 147 geriatric medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 300 | $273,460 |
| OzempicSemaglutide | 136 | $158,180 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 98 | $87,896 |
| JanuviaSitagliptin Phosphate | 52 | $66,497 |
| XareltoRivaroxaban | 44 | $36,980 |
| MyrbetriqMirabegron | 39 | $35,343 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 57 | $31,847 |
| Breo ElliptaFluticasone/Vilanterol | 44 | $21,508 |
| JardianceEmpagliflozin | 13 | $21,487 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $14,264 |
| MounjaroTirzepatide | 15 | $14,163 |
| EntrestoSacubitril/Valsartan | 18 | $13,744 |
| Tresiba Flextouch U-200Insulin Degludec | 21 | $12,651 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $12,618 |
| Metoprolol Succinate | 838 | $12,314 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $1,804 | $273,460300 claims |
| Novo NordiskOzempic | $204 | $158,180136 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $937 | $109,405142 claims |
| MerckJanuvia, Janumet Xr, Lagevrio (Eua) | $74 | $106,214125 claims |
| Johnson & JohnsonXarelto | $207 | $36,98044 claims |
| Astellas Pharma US IncMyrbetriq | $84 | $35,34339 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $197 | $32,93732 claims |
| AstraZenecaBreztri Aerosphere | $483 | $14,26422 claims |
| Lilly USA, LLCMounjaro | $292 | $14,16315 claims |
| NovartisEntresto | $82 | $13,74418 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $11,853943 claims |
| AbbVieSynthroid | $482 | $4,90393 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 147 geriatric medicine providers in Illinois.
Other geriatric medicine in Palos Heights
- Raj ShahChicago$1.8M
- Xinqi DongChicago$214K
- Michael LimArlington Heights$29K
- Patricia BurkeChicago$28K
- Hima AtluriDecatur$21K
- Carlos Mella-PicelChicago$9K
- Rekha SharmaHazel Crest$8K
- Azeem AhsanCrest Hill$6K
- Adeela CheemaChicago$5K
- Alex SanchezElgin$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.